Skip to main content

Table 1 Patient characteristics

From: Clinical impact of myosteatosis measured by magnetic resonance imaging on long-term outcomes of hepatocellular carcinoma after radical hepatectomy

Parameters

Myosteatosis negative (n = 122)

Myosteatosis positive (n = 65)

p value

Preoperative parameters

   

Age (years)

66 ± 0.89

73 ± 1.22

< 0.01

Sex (male/female)

93/29

47/18

0.55

BMI

23.4 ± 0.29

24.1 ± 0.40

0.16

Etiology (HBV・HCV/Others)

70/52

32/33

0.28

DM (- / +)

78/44

41/24

0.51

HT (- / +)

66/56

25/40

0.07

Plt (×104/µL)

18.2 ± 0.72

19.1 ± 0.99

0.44

T-bil (mg/dL)

0.86 ± 0.02

0.77 ± 0.03

0.03

Alb (g/ml)

4.0 ± 0.04

3.8 ± 0.05

0.02

TLC (/µl)

519 ± 80

700 ± 112

0.19

NLR

2.51 ± 0.13

2.81 ± 0.19

0.20

ICG R15 (%)

11.6 ± 0.85

14.0 ± 1.16

0.10

Child-Pugh class (A/B)

120/2

63/2

0.73

AFP (ng/ml)

3393 ± 1813

5185 ± 2474

0.56

Tumor factor

   

Tumor number (Solitary/Multiple)

95/27

53/12

0.55

Tumor size (cm)

4.33 ± 0.26

4.70 ± 0.35

0.40

Diff (Well/Mode/Poor)

17/92/13

11/49/5

0.04

vp (- / +)

101/21

51/14

0.47

vv (- / +)

113/9

64/1

0.06

Stage (I/II/III/IV)

21 / 60 / 34 / 7

8 / 35 / 19 / 3

0.80

Perioperative parameters

   

Type of surgery (major/minor)

96/26

54/11

0.46

Operative time (min)

306 ± 6.2

296 ± 8.4

0.37

Blood loss (ml)

235 ± 20

174 ± 27

0.07

Postoperative complication (< Grade III / Grade III)

121/1

65/0

0.35

  1. BMI: body mass index
  2. HBV: hepatitis B Virus
  3. HCV: hepatitis B Virus
  4. DM: diabetes mellitus
  5. HT: hypertension
  6. Plt: platelet count
  7. T-bil: total bilirubin
  8. Alb: albumin
  9. TLC: total lymphocyte count
  10. NLR: neutrophil-to-lymphocyte ratio
  11. ICG: indocyanine green
  12. AFP: α-fetoprotein
  13. Diff: differentiation
  14. vp: portal vein invasion
  15. vv: hepatic vein invasion